On January 31st, the European Commission launched proposals on Health Technology Assessment (HTA) in which it outlines mandatory use of joint clinical assessments reports, after a three-year transition period.
This proposal could go a long way to allowing HTA agencies to catch up with a scientific arena that is moving forward quickly, and IPPOSI welcomes this move.
By the end of the transition period, “all medicinal products falling within the scope and granted marketing authorisation in a given year will be assessed”. This also covers selected medical devices.
IPPOSI is calling on the European Parliament and Member States to adopt the EC proposal, and for Irish representatives to clearly advocate for its adoption through the legislative procedure.
The IPPOSI response to the EC plan can be read in full by clicking on the button below.
For more on IPPOSI’s work in the area of Health Technology Assessments, click on the button below: